 |
|
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim,
Clin Mol Hepatol. 2023;29(3):521-541. Published online 2023 Jul 1 DOI: https://doi.org/10.3350/cmh.2023.0202
|
|
Citations to this article as recorded by
 Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
Jiahao Li, Yingnan Liu, Ruipeng Zheng, Chao Qu, Jiarui Li
Life Sciences.2024; 342: 122540. CrossRef Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
Hyo-Cheol Kim
Clinical and Molecular Hepatology.2023; 29(4): 984. CrossRef Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion
Dan Yang, Jiaojiao Du, Weijie Nie, Chaozhi Wang, Zhufang Ma
Medicine.2023; 102(45): e35713. CrossRef
|